ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.

Seong Joon Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.